Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 TrialsJohn R Ingram, Alexa B. Kimball, Łukasz Matusiak et al.|Dermatology and Therapy|2025Cited by 2